EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families

Betul Gemici Karaaslan, Mehdi Benamar, Selami Ulas, Sezin Aydemir, Gozde Yesil, Alper Gezdirici, Aysun Ayaz Sari, Serdar Nepesov, Haluk Cokugras, Yildiz Camcioglu, Akif Ayaz, Cigdem Aydogmus und 3 weitere

Journal of Clinical Immunology · 29.03.2026 · 46 (1)

DOI: 10.1007/s10875-026-02012-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Immunology, online erschienen am 29.03.2026. Verfasst von Betul Gemici Karaaslan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Immunology and Allergy, School of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapasa, Fatih Istanbul, 34098, Türkiye. Hauptthemen laut MEDLINE: Phosphoglucomutase, Phenotype, Mutation, Genetic Predisposition to Disease. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Istanbul University Cerrahpaşa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phosphoglucomutase 3 deficiency (PGM3 deficiency) is a rare congenital disorder of glycosylation classically associated with severe immunodeficiency, skeletal abnormalities, and neurodevelopmental impairment. However, emerging evidence suggests that PGM3 deficiency may also present with attenuated or milder clinical phenotypes. In this study, we describe patients with a novel PGM3 variant exhibiting a less severe immunological and clinical presentation, thereby expanding the known phenotypic spectrum of PGM3 deficiency.

Methods

Demographic-data and Wechsler Intelligence Scale for Children profiles were evaluated alongside laboratory data, including complete blood cell counts, lymphocyte subsets, serum immunoglobulin levels, vaccine antibody titers, and lymphocyte cytokine profiles. Whole exome sequencing was conducted, and phospho-flow assays were utilized for the analysis of p-STATs.

Results

Five patients with a mild form of PGM3 deficiency were described, exhibiting a Hyper-IgE Syndrome phenotype without severe skeletal dysplasia or dysmorphism, with the exception of one patient displaying very mild skeletal dysplasia and three patients exhibiting mild to moderate intellectual disability. All patients demonstrated an increase in Natural Killer T cells and a decrease in B cells, alongside an increase in activated CD4 + T cells (CD45RO+), a decrease in naïve CD4 + and CD8 + T cells (CD45RA+ CCR7+), and an increase in TEMRA CD8 + T cells (CD45RA+CCR7–). Functional analysis of all patients revealed impaired PGM3 function, as evidenced by decreased surface expression of gp130 and p-STAT3.

Conclusion

Defective glycosylation in PGM3 deficiency leads to reduced gp130 expression and attenuated gp130-dependent STAT3 phosphorylation. The resulting cellular features partially overlap with those observed in STAT3 loss-of-function and gp130 deficiency, supporting a shared signaling mechanism while remaining clinically distinct.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphoglucomutasePhenotypeMutationGenetic Predisposition to DiseaseHumansFemaleMaleChild, PreschoolChildImmunophenotypingPedigreeExome SequencingSTAT3 Transcription FactorGenetic Association StudiesInfant

Stichwörter der Autor:innen

Hyper IgE syndromePhosphoflow assayPhosphoglucomutase-3

Substanzen

PhosphoglucomutasePGM3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Pediatric Immunology and Allergy, School of Medicine, Istanbul University-Cerrahpaşa, Kocamustafapasa, Fatih Istanbul, 34098, Türkiye.
  • Division of Immunology, Boston Children's Hospital, Boston, MA, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Institute of Regenerative Medicine and Biotherapy, INSERM, University of Montpellier, Montpellier, France.
  • Department of Pediatric Immunology and Allergy, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
  • Department of Medical Genetics, Istanbul University Faculty of Medicine, Istanbul, Türkiye.

Förderung

  • Istanbul University Cerrahpaşa

Zitieren

APA

Gemici Karaaslan, B., Benamar, M., Ulas, S., Aydemir, S., Yesil, G., Gezdirici, A., Sari, A. A., Nepesov, S., Cokugras, H., Camcioglu, Y., Ayaz, A., Aydogmus, C., Charbonnier, L. M., Chatila, T., & Kiykim, A. (2026). A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02012-2

Vancouver

Gemici Karaaslan B, Benamar M, Ulas S, Aydemir S, Yesil G, Gezdirici A, et al. A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02012-2

BibTeX
@article{GemiciKaraaslan2026,
  author = {Gemici Karaaslan, Betul and Benamar, Mehdi and Ulas, Selami and Aydemir, Sezin and Yesil, Gozde and Gezdirici, Alper and Sari, Aysun Ayaz and Nepesov, Serdar and Cokugras, Haluk and Camcioglu, Yildiz and Ayaz, Akif and Aydogmus, Cigdem and Charbonnier, Louis-Marie and Chatila, Talal and Kiykim, Ayca},
  title = {A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10875-026-02012-2}
}
Kostenlos starten →